Gastroenterology

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma

Source link




Related posts

IBD prevalence in the UK significantly higher than previous estimates

Newsemia

Lessons Learned From and Future Opportunities for Global Health Endeavors by 2 Academic Gastroenterology Units

Newsemia

Fight CRC publishes manuscript investigating colon and rectal cancer in young adults

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy